Ketaminhydrochlorid Inresa

Ketamine Hydrochloride, the active ingredient in Ketaminhydrochlorid Inresa, is a dissociative anesthetic presented as a sterile injectable solution for intramuscular and intravenous use. It provides induction of anesthesia, procedural sedation and analgesia for patients undergoing surgery or painful procedures. GNH USA supplies Ketaminhydrochlorid Inresa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketamine Hydrochloride acts on the central nervous system as an NMDA‑receptor antagonist, making it useful in several procedural settings. - Induction of anesthesia: enables rapid loss of consciousness for surgical procedures. - Procedural sedation: provides calmness and pain relief during diagnostic or minor therapeutic interventions. - Analgesia: offers potent pain control for acute severe pain when other agents are insufficient.

Ketamine Hydrochloride may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness. - Nausea and vomiting. - Increased salivation. - Blurred vision or visual disturbances. - Transient hypertension or tachycardia. - Emergence phenomena such as vivid dreams.

Serious or Rare Side Effects: - Severe respiratory depression (rare when used alone). - Profound hypertension or arrhythmias. - Persistent hallucinations or delirium. - Allergic reactions including anaphylaxis. - Urinary tract toxicity with prolonged use. - Elevated intracranial pressure in susceptible patients.

Ketamine should be administered with careful clinical monitoring. - Airway assessment: ensure airway patency and have resuscitation equipment ready. - Cardiovascular monitoring: observe blood pressure and heart rate continuously. - Psychiatric history: use cautiously in patients with schizophrenia or severe mood disorders. - Hypertension: avoid in uncontrolled hypertension or severe cardiovascular disease. - Hepatic impairment: consider dose reduction and monitor liver function. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Ketamine can interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Central nervous system depressants (e.g., opioids, benzodiazepines): may cause profound sedation or respiratory depression. - Monoamine oxidase inhibitors (MAOIs): can increase risk of hypertensive crisis. - Sympathomimetic agents (e.g., epinephrine): may precipitate severe hypertension.

Moderate Interactions (Monitor Closely): - CYP2B6 inhibitors or inducers (e.g., rifampin, carbamazepine): may affect ketamine metabolism. - Antihypertensive drugs: ketamine‑induced hypertension may counteract blood‑pressure control. - Anticholinergic agents: may exacerbate dry mouth or urinary retention.